No article text was recorded for this version.
humoral-cellular immunity gap
Version 2 of 281 papers87 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial
- Blog: Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost
- Blog: Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America
- Blog: Effects of Systemically Administered Hydrocortisone on the Human Immunome
- Blog: Myeloid‐Driven Immune Suppression Subverts Neutralizing Antibodies and T Cell Immunity in Severe COVID‐19
- Blog: Construction and in vitro evaluation of a recombinant live attenuated PRRSV expressing GM-CSF
- Blog: Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials
- Blog: Safety, efficacy and immunogenicity evaluation of the SAG2 oral rabies vaccine in Formosan ferret badgers
- Blog: Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy
- Blog: Роль российских ученых в разработке сибиреязвенных вакцин
- Blog: Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans
- Blog: Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters
- Blog: Antibodies to SARS-CoV-2 are associated with protection against reinfection
- Blog: Omicron COVID-19 Immune Correlates Analysis of a Third Dose of mRNA-1273 in the COVE Trial
- Blog: POS1246 COVID-19 IN RITUXIMAB TREATED PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES
- Blog: Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial
- Blog: SARS-CoV-2 B.1.617.2 Delta variant emergence and vaccine breakthrough
- Blog: Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status
- Blog: Early Computational Detection of Potential High Risk SARS-CoV-2 Variants
- Blog: Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over Time
- Blog: Modeling the evolution of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2
- Blog: Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
- Blog: Kinetics of severe acute respiratory syndrome coronavirus 2 infection antibody responses
- Blog: Immune Persistence against SARS-CoV-2 after Primary and Booster Immunization in Humans: A Large-Scale Prospective Cohort Study
- Blog: Fluorescent Cell Chip a new in vitro approach for immunotoxicity screening
- Blog: A Novel Targeted RIG-I Receptor 5′Triphosphate Double Strain RNA-Based Adjuvant Significantly Improves the Immunogenicity of the SARS-CoV-2 Delta-Omicron Chimeric RBD-Dimer Recombinant Protein Vaccine
- Blog: Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2
- Blog: Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine
- Blog: Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV- POPART cohort participants
- Blog: Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV
- Blog: Development and Validation of Novel Cell-free Direct Neutralization Assay for SARS-CoV-2
- Blog: Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
- Blog: SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection
- Blog: A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland
- Blog: Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial
- Blog: Bovine β-Casein Peptide YPFPGPIH Regulates Inflammation and Macrophage Activity via TLR/NF-κB/MAPK Signaling
- Blog: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan
- Blog: In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients
- Blog: Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection
- Blog: Ecological Succession of Airborne Bacterial Aerosols in Poultry Houses: Insights from Taihang Chickens
- Blog: Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine
- Blog: Durable natural killer cell responses after heterologous two-dose Ebola vaccination
- Blog: Effect of Rearing Systems on Growth Performance, Lying/Standing Behavior, Morbidity, and Immunity Parameters of Pre-Weaned Dairy Calves in a Continental Zone in Winter
- Blog: Anti-Inflammatory Effects of Recombinant Human PDCD5 (rhPDCD5) in a Rat Collagen-Induced Model of Arthritis
- Blog: Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape over Time
- Blog: The effects of dexmedetomidine on postoperative tumor recurrence and patient survival after breast cancer surgery: a feasibility study
- Blog: Study on age-dependent pre-existing 2009 pandemic influenza virus T and B cell responses from Chinese population
- Blog: Immune response stability to the SARS-CoV-2 mRNA vaccine booster is influenced by differential splicing of HLA genes
- Blog: Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
- Blog: The impact of SARS-CoV-2 vaccines on antibody responses in the general population in the United Kingdom
- Blog: Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy
- Blog: Immune responses to inactivated COVID-19 vaccine were decreased in Chinese patients with chronic respiratory diseases
- Blog: Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features
- Blog: Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial
- Blog: HIV specific CD8+ TRM-like cells in tonsils express exhaustive signatures in the absence of natural HIV control
- Blog: Computationally designed proteins mimic antibody immune evasion in viral evolution
- Blog: Assessing factors associated with one-year antibody waning in participants with repeated influenza vaccinations: A six-year cohort study
- Blog: Live Attenuated aTJ Vaccine Effectively Protects Pigeons Against Homologous PPMV-1 Challenge
- Blog: Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial
- Blog: Effects of aging on serum antibody titers against periodontopathic bacteria.
Showing 60 of 81 papers.
History & citation
Current · Permanent link
- variant-specific protective thresholds split from this direction (55% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_humoral_cellular_immunity_gap_7fe73cef,
title = {humoral-cellular immunity gap},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/humoral-cellular-immunity-gap/rdr_7fe73cefb46544179e95cd126ad551b7},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 2, frozen text):
@misc{lacuna_humoral_cellular_immunity_gap_7fe73cef_v2,
title = {humoral-cellular immunity gap},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/humoral-cellular-immunity-gap/rdr_7fe73cefb46544179e95cd126ad551b7/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-19},
}